BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 17646625)

  • 1. Patient-reported autonomic symptoms in Parkinson disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; van Hilten JJ
    Neurology; 2007 Jul; 69(4):333-41. PubMed ID: 17646625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT.
    Visser M; Marinus J; Stiggelbout AM; Van Hilten JJ
    Mov Disord; 2004 Nov; 19(11):1306-12. PubMed ID: 15390007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
    Kim HJ; Park SY; Cho YJ; Hong KS; Cho JY; Seo SY; Lee DH; Jeon BS
    J Neurol Sci; 2009 Dec; 287(1-2):200-4. PubMed ID: 19700173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Verbaan D; van Rooden SM; Visser M; Marinus J; van Hilten JJ
    Mov Disord; 2008 Jan; 23(1):35-41. PubMed ID: 17960797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
    Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
    J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive daytime sleepiness and subsequent development of Parkinson disease.
    Abbott RD; Ross GW; White LR; Tanner CM; Masaki KH; Nelson JS; Curb JD; Petrovitch H
    Neurology; 2005 Nov; 65(9):1442-6. PubMed ID: 16275833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
    Minguez-Castellanos A; Chamorro CE; Escamilla-Sevilla F; Ortega-Moreno A; Rebollo AC; Gomez-Rio M; Concha A; Munoz DG
    Neurology; 2007 Jun; 68(23):2012-8. PubMed ID: 17548551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
    Chitnis S
    Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of bowel symptoms in Parkinson's disease.
    Krogh K; Ostergaard K; Sabroe S; Laurberg S
    Acta Neurol Scand; 2008 Jan; 117(1):60-4. PubMed ID: 18095955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
    Cubo E; Martín PM; Martin-Gonzalez JA; Rodríguez-Blázquez C; Kulisevsky J;
    Mov Disord; 2010 Jan; 25(1):70-5. PubMed ID: 20014110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
    Gallagher DA; Lees AJ; Schrag A
    Mov Disord; 2010 Nov; 25(15):2493-500. PubMed ID: 20922807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Vendette M; Gagnon JF; Décary A; Massicotte-Marquez J; Postuma RB; Doyon J; Panisset M; Montplaisir J
    Neurology; 2007 Nov; 69(19):1843-9. PubMed ID: 17984452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic and cognitive functions in Parkinson's disease (PD).
    Oh ES; Lee JH; Seo JG; Sohn EH; Lee AY
    Arch Gerontol Geriatr; 2011; 52(1):84-8. PubMed ID: 20223528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
    Biglan KM; Holloway RG; McDermott MP; Richard IH;
    Neurology; 2007 Jul; 69(2):187-95. PubMed ID: 17620552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
    Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.